ATE414530T1 - Lactalbumin zur kurativen behandlung von magengeschwüren - Google Patents

Lactalbumin zur kurativen behandlung von magengeschwüren

Info

Publication number
ATE414530T1
ATE414530T1 AT00937288T AT00937288T ATE414530T1 AT E414530 T1 ATE414530 T1 AT E414530T1 AT 00937288 T AT00937288 T AT 00937288T AT 00937288 T AT00937288 T AT 00937288T AT E414530 T1 ATE414530 T1 AT E414530T1
Authority
AT
Austria
Prior art keywords
lactalbumin
curative treatment
stomach ulcer
antiulcer agents
ulcer
Prior art date
Application number
AT00937288T
Other languages
English (en)
Inventor
Hirotoshi Hayasawa
Tomohiro Toida
Yukiko Shimokawa
Hiroshi Matsumoto
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Application granted granted Critical
Publication of ATE414530T1 publication Critical patent/ATE414530T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00937288T 1999-07-28 2000-06-16 Lactalbumin zur kurativen behandlung von magengeschwüren ATE414530T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21378299 1999-07-28

Publications (1)

Publication Number Publication Date
ATE414530T1 true ATE414530T1 (de) 2008-12-15

Family

ID=16644960

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00937288T ATE414530T1 (de) 1999-07-28 2000-06-16 Lactalbumin zur kurativen behandlung von magengeschwüren

Country Status (9)

Country Link
US (1) US6815419B1 (de)
EP (1) EP1210949B1 (de)
JP (1) JP3756449B2 (de)
AT (1) ATE414530T1 (de)
CA (1) CA2373166C (de)
DE (1) DE60040856D1 (de)
DK (1) DK1210949T3 (de)
ES (1) ES2316368T3 (de)
WO (1) WO2001007077A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202100032549A1 (it) * 2021-12-23 2023-06-23 Laboratorio Della Farm S P A Composizione orale a base di glicerolo, polisaccaridi gelificanti e un sistema tampone

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2095259A (en) * 1934-08-03 1937-10-12 Searle & Co Mucinous preparations
US2520615A (en) * 1947-06-27 1950-08-29 Laval Separator Co De Process for recovery of lactalbumin
US2585225A (en) * 1947-08-23 1952-02-12 Scherer Corp R P Process for hydrolyzing lactalbumin
US2832717A (en) * 1952-07-14 1958-04-29 Jr Edgar A Ferguson Partially hydrolyzed brominated protein
FR2459620B1 (fr) 1979-06-26 1983-08-05 Agronomique Inst Nat Rech Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
JPS62277327A (ja) 1986-05-26 1987-12-02 Fujisawa Pharmaceut Co Ltd 抗潰瘍物質
JPS6339545A (ja) * 1986-08-04 1988-02-20 Meiji Milk Prod Co Ltd 牛乳ホエ−中のβ−ラクトグロブリンの除去方法
DE3712890A1 (de) 1987-04-15 1988-10-27 Teichmann Reinhard K Priv Doz Verwendung antigener substanzen zur prophylaxe oder therapie von stoerungen und krankheiten im verdauungstrakt von tieren und menschen
US5725861A (en) 1987-04-15 1998-03-10 Effem Gmbh Products and processes for gastric cascade and gastrointestinal disorder treatment with same
JPH0288522A (ja) 1988-09-26 1990-03-28 Nippon Hai Potsukusu:Kk 非ステロイド性抗炎症剤組成物及びその製造方法
ATE287415T1 (de) 1990-07-13 2005-02-15 Gropep Ltd Wachstumsfördernder wirkstoff
JP2907603B2 (ja) 1991-09-09 1999-06-21 雪印乳業株式会社 新規生理活性ペプチド、該活性ペプチドを有効成分とする胃酸分泌抑制剤、抗潰瘍剤及び飲食品
JP3018305B2 (ja) 1992-02-03 2000-03-13 雪印乳業株式会社 プロテオースペプトンコンポーネント８ｆを有効成分とする胃酸分泌抑制剤、抗潰瘍剤及び飲食品
JP3123618B2 (ja) 1992-03-18 2001-01-15 雪印乳業株式会社 新規ペプチド、該ペプチドを有効成分とする胃酸分泌抑制−抗潰瘍剤及び飲食品
JP3108518B2 (ja) 1992-03-26 2000-11-13 雪印乳業株式会社 胃潰瘍予防または治療のための医薬及び食品添加物
US6027735A (en) 1992-07-28 2000-02-22 Effem Gmbh Products and processes for gastric cascade and gastrointestinal disorder treatment with same
JPH07203863A (ja) 1994-01-14 1995-08-08 Kyodo Nyugyo Kk 牛乳ホエ−由来β−ラクトグロブリン、α−ラクトアルブミン及びラクトフエリンの製造法
ATE182470T1 (de) * 1994-08-16 1999-08-15 Hemant Sabharwal Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung
JP3058920B2 (ja) 1996-04-19 2000-07-04 一男 坪田 アルブミンを有効成分とする医薬組成物
DE69837719T2 (de) * 1997-11-21 2008-01-31 Nya Hamlet Pharma Ab Herstellungsverfahren von lactalbumin
JP2000063284A (ja) * 1998-08-21 2000-02-29 Terumo Corp 炎症性腸疾患再燃防止剤

Also Published As

Publication number Publication date
ES2316368T3 (es) 2009-04-16
DE60040856D1 (de) 2009-01-02
DK1210949T3 (da) 2009-03-09
EP1210949A1 (de) 2002-06-05
EP1210949A4 (de) 2003-03-19
CA2373166C (en) 2009-05-19
CA2373166A1 (en) 2001-02-01
JP3756449B2 (ja) 2006-03-15
EP1210949B1 (de) 2008-11-19
US6815419B1 (en) 2004-11-09
WO2001007077A1 (fr) 2001-02-01

Similar Documents

Publication Publication Date Title
MX9202449A (es) 3-aminoquinuclidinas substituidas.
TR200101335T2 (tr) İktidarsızlık tedavisi için pirazolopirimidinon türevleri
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
CA2396561A1 (en) Substituted oxazolidinones and their use in the field of blood coagulation
DE60043318D1 (de) Synergistische kombination von pumafentrine und salmeterol
DE60321929D1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE218582T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
IL152659A (en) Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
NO910213D0 (no) Fremgangsmaate for fremstilling av orale legemiddelformer av pimobendan.
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
TR200002626T2 (tr) Terkip
CA2217513A1 (en) Pharmaceutical agents for the treatment of alzheimer's disease
TR199802200A2 (xx) S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi.
ATE342734T1 (de) Adenosin a1 antagonisten gegen männliche sterilität
ATE414530T1 (de) Lactalbumin zur kurativen behandlung von magengeschwüren
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
EP1352657A4 (de) Therapeutische mittel die die wirkung von interferon verstarken
TR200102009T2 (tr) Serebral işlemi profilaksı ve tedavisi için formül I'e göre bileşiklerin kullanımı
MA23429A1 (fr) Novelle forme galenique de derives de 5-nitro imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus-gastro-intestinal.
RU2001128736A (ru) Способ нормализации воспроизводительной функции коров

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1210949

Country of ref document: EP